Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TGN1412--a regulator's perspective.
Schneider CK, Kalinke U, Löwer J. Schneider CK, et al. Among authors: kalinke u. Nat Biotechnol. 2006 May;24(5):493-6. doi: 10.1038/nbt0506-493. Nat Biotechnol. 2006. PMID: 16680120 No abstract available.
Toward experimental assessment of receptor occupancy: TGN1412 revisited.
Waibler Z, Sender LY, Kamp C, Müller-Berghaus J, Liedert B, Schneider CK, Löwer J, Kalinke U. Waibler Z, et al. Among authors: kalinke u. J Allergy Clin Immunol. 2008 Nov;122(5):890-2. doi: 10.1016/j.jaci.2008.07.049. Epub 2008 Sep 20. J Allergy Clin Immunol. 2008. PMID: 18805577
Toward biosimilar monoclonal antibodies.
Schneider CK, Kalinke U. Schneider CK, et al. Among authors: kalinke u. Nat Biotechnol. 2008 Sep;26(9):985-90. doi: 10.1038/nbt0908-985. Nat Biotechnol. 2008. PMID: 18779806 No abstract available.
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G. Paran N, et al. Among authors: kalinke u. J Infect Dis. 2009 Jan 1;199(1):39-48. doi: 10.1086/595565. J Infect Dis. 2009. PMID: 19012492
The regulatory landscape for actively personalized cancer immunotherapies.
Britten CM, Singh-Jasuja H, Flamion B, Hoos A, Huber C, Kallen KJ, Khleif SN, Kreiter S, Nielsen M, Rammensee HG, Sahin U, Hinz T, Kalinke U. Britten CM, et al. Among authors: kalinke u. Nat Biotechnol. 2013 Oct;31(10):880-2. doi: 10.1038/nbt.2708. Nat Biotechnol. 2013. PMID: 24104749 No abstract available.
262 results